Rheumatoid Arthritis

AB0284 EVALUATION OF THE RELATIONSHIP BETWEEN SERUM NETRIN-1 LEVEL AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS
G. Ozan, S. Erten, S. C. Güven, A. Kor, F. Eren, P. Akyüz Dağli, Y. Maraş, I. Dogan, K. Gok, O. Küçükşahin, B. Armagan, S. Neşelioğlu, S. Başer, O. Erel

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1322-1323; DOI: 10.1136/annrheumdis-2023-eular.6270
AB0300 GENETIC EVIDENCE REVEALS A CAUSAL RELATIONSHIP BETWEEN RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE
Y. W. Zhang, R. Zhao, J. C. Guo, J. Y. Yao, S. X. Zhang, X. Li, C. Wang

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1332-1333; DOI: 10.1136/annrheumdis-2023-eular.3767
AB0305 HOW DOES PSYCHOLOGICAL TRAUMA AFFECT THE COURSE OF RHEUMATOID ARTHRITIS?
A. Nurmamedov, S. Lezhenina, N. Shuvalova, E. Guryanova

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1336; DOI: 10.1136/annrheumdis-2023-eular.1958
AB0351 RELATIONSHIP BETWEEN NUTRITIONAL STATUS AND OSTEOPOROSIS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
M. Ardhaoui, M. Ghali, J. Mahbouba, S. Zrour, I. Bejia, M. Touzi, N. Bergaoui

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1359; DOI: 10.1136/annrheumdis-2023-eular.4696
AB0427 ADHERENCE ANALYSIS OF REAL-WORLD EVIDENCE FOR ADALIMUMAB BIOSIMILAR MSB11022 THERAPY IN RHEUMATOLOGIC DISEASES
S. Cheung, D. Truong

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1402; DOI: 10.1136/annrheumdis-2023-eular.4037
AB0430 MEDICATION ADHERENCE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC OR TARGET SYNTETIC -DMARDS: EVALUATION OF PREDICTIVE FACTORS IN AN ITALIAN MONOCENTRIC COHORT
L. Moschetti, C. Bazzani, F. Delvecchio, F. Franceschini

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1404; DOI: 10.1136/annrheumdis-2023-eular.5491
AB0473 THE EFFICACY OF METHOTREXATE MONOTHERAPY STRATEGY CHOSEN AS FIRST-LINE DMARD THERAPY IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS: RETROSPECTIVE EVALUATION OF SINGLE TERTIARY CENTER EXPERIENCE
N. Erdik, C. Arslantürk Güneysu, S. M. Türk, G. Yavuzbilge, D. Karatas, M. Kalçik Unan, E. Gönüllü

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1429-1430; DOI: 10.1136/annrheumdis-2023-eular.1886
AB0472 FILGOTINIB FOR RHEUMATOID ARTHRITIS - AN OBSERVATIONAL STUDY TO ASSESS CLINICAL EFFECTIVENESS IN NHS LOTHIAN
C. Box, E. Swann, H. Harris, N. Mckay

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1429; DOI: 10.1136/annrheumdis-2023-eular.1872
AB0474 REAL-WORLD SINGLE CENTER USE OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS, INCLUDING THOSE REFRACTORY TO FIRST-GENERATION JAK INHIBITORS
M. Kamiya, S. Mori, K. Yamazaki, N. Oka, N. Shoukaku, D. Togawa

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1430; DOI: 10.1136/annrheumdis-2023-eular.1902
AB0511 A PHASE 1, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE-DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN PATIENTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS
S. Cohen, J. Beebe, V. Chindalore, S. Guan, M. Hassan-Zahraee, C. Hyde, S. Koride, R. Levin, S. Lubaczewski, M. Salganik, A. Sloan, E. Stevens, E. Peeva, M. Vincent, D. Martin, M. Chu

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1450; DOI: 10.1136/annrheumdis-2023-eular.95

Main menu

Rheumatoid Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Rheumatoid Arthritis

Pages